Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Inhibitors of beta-amyloid peptide production or release discovered at Lilly

June 27, 2001

Combination of PDE4 and PDE3 inhibitors for Th1-mediated autoimmune diseases

June 27, 2001

Copper/zinc chelator may address underlying cause of Alzheimer's disease

June 26, 2001

AstraZeneca's Zomig approved in Japan for migraine

June 25, 2001

NMDA antagonists with anticonvulsant activity synthesized at Merz

June 22, 2001

Novel compounds act as antagonists at 5-ht6 receptors and are useful for Rx of CNS disorders

June 22, 2001

Viragen cleared to begin clinical trials of Omniferon for MS in the U.K.

June 22, 2001

Prescient NeuroPharma identifies neurotrophic factor genes

June 22, 2001

Major beneficial effects reported for DP-b99 in focal and global cerebral ischemia

June 22, 2001

Synthetic peptides inhibit interaction between prion protein isoforms

June 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...